Found 4 matching trials
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
PHASE1This phase I trial studies the side effects and best dose of autologous den...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured
PHASE1RATIONALE: Vaccines made from gene-modified tumor cells may help the body b...
Location
H. Lee Moffitt Cancer Center and Research Institute
A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer
PHASE1The purpose of this study is to determine the dose that the vaccine can be ...
Location
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
PHASE1RATIONALE: Vaccines made from a gene-modified virus may help the body build...
Location
VA Greater Los Angeles